Atlantic Union Bankshares’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.79M Sell
9,539
-641
-6% -$211K 0.05% 249
2025
Q4
$3.57M Sell
10,180
-834
-8% -$282K 0.07% 229
2025
Q3
$3.56M Buy
11,014
+583
+6% +$181K 0.07% 234
2025
Q2
$4.06M Buy
10,431
+8,036
+336% +$3.23M 0.09% 192
2025
Q1
$1.04M Sell
2,395
-887
-27% -$356K 0.06% 177
2024
Q4
$1.21M Sell
3,282
-3,382
-51% -$1.42M 0.07% 176
2024
Q3
$3.47M Sell
6,664
-589
-8% -$315K 0.2% 114
2024
Q2
$3.93M Buy
7,253
+6,683
+1,172% +$3.53M 0.25% 94
2024
Q1
$296K Hold
570
0.02% 247
2023
Q4
$269K Sell
570
-13
-2% -$6.01K 0.02% 259
2023
Q3
$254K Hold
583
0.03% 256
2023
Q2
$259K Sell
583
-50
-8% -$23.1K 0.03% 259
2023
Q1
$291K Sell
633
-50
-7% -$23.8K 0.03% 245
2022
Q4
$350K Sell
683
-17
-2% -$8.63K 0.04% 211
2022
Q3
$318K Sell
700
-1,453
-67% -$695K 0.04% 199
2022
Q2
$1.04M Sell
2,153
-55
-2% -$27.2K 0.11% 130
2022
Q1
$1.08M Sell
2,208
-58
-3% -$26.5K 0.09% 140
2021
Q4
$1.05M Sell
2,266
-147
-6% -$61.8K 0.09% 139
2021
Q3
$900K Sell
2,413
-80
-3% -$30.4K 0.08% 151
2021
Q2
$951K Hold
2,493
0.09% 151
2021
Q1
$895K Sell
2,493
-260
-9% -$83.6K 0.09% 146
2020
Q4
$884K Buy
2,753
+110
+4% +$33.8K 0.09% 150
2020
Q3
$710K Sell
2,643
-954
-27% -$257K 0.08% 154
2020
Q2
$946K Buy
3,597
+385
+12% +$103K 0.12% 141
2020
Q1
$729K Sell
3,212
-325
-9% -$88.6K 0.11% 151
2019
Q4
$1.07M Sell
3,537
-25
-0.7% -$6.88K 0.14% 138
2019
Q3
$856K Buy
3,562
+133
+4% +$36.4K 0.11% 147
2019
Q2
$967K Buy
3,429
+1,027
+43% +$281K 0.13% 142
2019
Q1
$689K Sell
2,402
-660
-22% -$191K 0.19% 82
2018
Q4
$805K Sell
3,062
-188
-6% -$51.7K 0.26% 75
2018
Q3
$891K Buy
3,250
+412
+15% +$107K 0.27% 72
2018
Q2
$675K Hold
2,838
0.22% 77
2018
Q1
$624K Sell
2,838
-457
-14% -$107K 0.19% 84
2017
Q4
$742K Buy
3,295
+6
+0.2% +$1.28K 0.23% 79
2017
Q3
$624K Sell
3,289
-330
-9% -$62.8K 0.21% 80
2017
Q2
$681 Buy
3,619
+49
+1% +$8.8K 0.24% 76
2017
Q1
$590 Sell
3,570
-303
-8% -$48.2K 0.21% 81
2016
Q4
$556K Sell
3,873
-882
-19% -$118K 0.21% 84
2016
Q3
$596K Sell
4,755
-63
-1% -$8.13K 0.23% 83
2016
Q2
$633K Buy
4,818
+641
+15% +$87.7K 0.24% 81
2016
Q1
$580K Sell
4,177
-194
-4% -$25.9K 0.24% 83
2015
Q4
$610K Sell
4,371
-130
-3% -$17.9K 0.27% 83
2015
Q3
$630K Buy
4,501
+2,003
+80% +$301K 0.29% 79
2015
Q2
$410K Buy
2,498
+194
+8% +$31K 0.19% 95
2015
Q1
$356K Sell
2,304
-586
-20% -$83.4K 0.16% 102
2014
Q4
$364K Sell
2,890
-212
-7% -$26.2K 0.16% 102
2014
Q3
$371K Sell
3,102
-197
-6% -$22.6K 0.17% 103
2014
Q2
$355K Buy
3,299
+2,871
+671% +$296K 0.17% 104
2014
Q1
$36K Buy
+428
New +$38.7K 0.02% 143

Other funds holding ELV

Atlantic Union Bankshares's ELV Position: Q1 2026 in Review

Atlantic Union Bankshares reduced its Elevance Health (ELV) stake by 6.3% in Q1 2026, selling an estimated $211K and leaving 9,539 shares worth $2.79M. The position accounts for 0.05% of the portfolio, ranked #249.

Atlantic Union Bankshares first reported a position in ELV in Q1 2014 and has held it in 49 quarters since. The position peaked at $4.06M in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Atlantic Union Bankshares held 9,539 shares of Elevance Health worth $2.79M as of Q1 2026.
  • Atlantic Union Bankshares sold 641 Elevance Health shares in Q1 2026, an estimated $211K.
  • Elevance Health made up 0.05% of Atlantic Union Bankshares's portfolio in Q1 2026, its #249 holding.
  • Atlantic Union Bankshares first reported a position in Elevance Health in Q1 2014 and has held it in 49 quarters since.
  • Atlantic Union Bankshares's Elevance Health position peaked at $4.06M in Q2 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.